Investigating the Impact of Multiple Pharmacy Use and Medication Adherence in Colorectal Cancer With Timothy Barnett, PharmD, CSP
Expert Perspectives · Keira Smith · 2024-09-09
At this year’s American Society of Clinical Oncology (ASCO) Annual Meeting, Timothy Barnett, PharmD, CSP, Clinical Program Manager of Specialty Manufacturer Services at CVS Health, presented his team’s study titled “The impact of multiple pharmacy use on medication adherence in individuals with colorectal cancer (CRC).” After returning from the meeting, Dr. Barnett sat down with Oncology Data Advisor to share additional insights into this important research, including:
- Background about multiple pharmacy use and its unintended consequences
- The specific impacts of multiple pharmacy use for patients with CRC
- The study that he and his team designed and what it investigated
- The results of the study and its implications for patient education and other clinical changes regarding multiple pharmacy use
- Next steps for the research
- Advice for pharmacists on how to counsel patients about medication adherence
- And more!
About Dr. Barnett
Timothy Barnett, PharmD, CSP, is the Clinical Program Manager of Specialty Manufacturer Services at CVS Health. In 2019, Tim joined CVS Specialty, where he worked in operations as a staff pharmacist, lead pharmacist, and then pharmacist supervisor for the Orlando Ultra Touch oncology team. Today, he serves as a Clinical Manager for Oncology and Hematology Therapies. Tim’s role supports the development, implementation, and management of therapy-specific clinical programs and services, which helps to support providers and patients achieve an advanced quality and effectiveness of their prescribed therapy. Tim received his Doctor of Pharmacy degree from Shenandoah University in Winchester, Virginia. He currently resides in Geneva, Florida, where he lives with his wife, two kids, dog, and two horses.